BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 18220289)

  • 21. Critical role of natural killer cells in the rejection of human hepatocytes after xenotransplantation into immunodeficient mice.
    Kawahara T; Douglas DN; Lewis J; Lund G; Addison W; Tyrrell DL; Churchill TA; Kneteman NM
    Transpl Int; 2010 Sep; 23(9):934-43. PubMed ID: 20180929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum apolipoprotein E as a marker to monitor graft function after hepatocyte transplantation in a clinically relevant mouse model.
    Jorns C; Takahashi T; Callaghan E; Zemack H; Larsson L; Nowak G; Parini P; Ericzon BG; Ellis E
    Transplant Proc; 2013 Jun; 45(5):1780-6. PubMed ID: 23769043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow transplantation results in donor-derived hepatocytes in an animal model of inherited cholestatic liver disease.
    Chen HL; Wang R; Chen HL; Hwu WL; Jeng YM; Chang MH; Ling V
    J Biomed Sci; 2008 Sep; 15(5):615-22. PubMed ID: 18509747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early regulation of CD8 T cell alloreactivity by CD4+CD25- T cells in recipients of anti-CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor-reactive CD8+ T cells, precluding a role for sustained regulation.
    Fehr T; Takeuchi Y; Kurtz J; Wekerle T; Sykes M
    Eur J Immunol; 2005 Sep; 35(9):2679-90. PubMed ID: 16082727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver tissue engineering utilizing hepatocytes propagated in mouse livers in vivo.
    Ohashi K; Tatsumi K; Tateno C; Kataoka M; Utoh R; Yoshizato K; Okano T
    Cell Transplant; 2012; 21(2-3):429-36. PubMed ID: 22793050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocyte growth factor/c-Met signalling is important for the selection of transplanted hepatocytes.
    Kaldenbach M; Giebeler A; Tschaharganeh DF; Erschfeld S; Wasmuth HE; Dolle L; Floege J; Trautwein C; Streetz KL
    Gut; 2012 Aug; 61(8):1209-18. PubMed ID: 22287599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A functional model of hepatocyte transplantation for in vivo immunologic studies.
    Bumgardner GL; Heininger M; Li J; Xia D; Parker-Thornburg J; Ferguson RM; Orosz CG
    Transplantation; 1998 Jan; 65(1):53-61. PubMed ID: 9448144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment.
    Shizuru JA; Jerabek L; Edwards CT; Weissman IL
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):3-14. PubMed ID: 9078349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human hepatoma HepaRG cell line engraftment in severe combined immunodeficient × beige mice using mouse-specific anti-Fas antibody.
    Jiang L; Li JG; Lan L; Wang YM; Mao Q; You JP
    Transplant Proc; 2010 Nov; 42(9):3773-8. PubMed ID: 21094855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
    Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Kwon CH; Joh JW; Kim SJ
    J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allogeneic intra-bone marrow transplantation prevents rheumatoid arthritis in SKG/Jcl mice.
    Kushida T; Ueda Y; Umeda M; Oe K; Okamoto N; Iida H; Abraham NG; Gershwin ME; Ikehara S
    J Autoimmun; 2009; 32(3-4):216-22. PubMed ID: 19349145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Replacement of liver parenchyma in analbuminemic rats with allogenic hepatocytes is facilitated by intrabone marrow-bone marrow transplantation.
    Inagaki M; Furukawa H; Satake Y; Okada Y; Chiba S; Nishikawa Y; Ogawa K
    Cell Transplant; 2011; 20(9):1479-89. PubMed ID: 21176395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
    Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
    Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chimerism and tolerance: from freemartin cattle and neonatal mice to humans.
    Jankowski RA; Ildstad ST
    Hum Immunol; 1997 Feb; 52(2):155-61. PubMed ID: 9077564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term immunologic tolerance induction in chimeric mice after bone marrow transplantation across major histocompatibility barriers: persistent or redeveloping immunologic responsiveness after prolonged survival.
    Sugiura K; Yasumizu R; Iwai H; Inaba MM; Toki J; Ogura M; Hara I; Good RA; Ikehara S
    Thymus; 1991 Nov; 18(3):137-53. PubMed ID: 1838450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocyte transplantation for total liver repopulation.
    Mizuguchi T; Mitaka T; Katsuramaki T; Hirata K
    J Hepatobiliary Pancreat Surg; 2005; 12(5):378-85. PubMed ID: 16258806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of biodistribution and engraftment into the liver of genetically modified mesenchymal stromal cells derived from adipose tissue.
    Di Rocco G; Gentile A; Antonini A; Truffa S; Piaggio G; Capogrossi MC; Toietta G
    Cell Transplant; 2012; 21(9):1997-2008. PubMed ID: 22469297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model.
    Bumgardner GL; Li J; Heininger M; Ferguson RM; Orosz CG
    Transplantation; 1998 Jan; 65(1):47-52. PubMed ID: 9448143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic tissue environment in NEMO-deficient mice critically regulates positive selection of donor cells after hepatocyte transplantation.
    Kaldenbach M; Cubero FJ; Erschfeld S; Liedtke C; Trautwein C; Streetz K
    PLoS One; 2014; 9(6):e100786. PubMed ID: 24979756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.